Patents by Inventor Charles F. BOSWORTH

Charles F. BOSWORTH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS OF USE FOR TREATING ABERRANT INFLAMMATION IN PERI-OCULAR SECRETORY GLANDS OR AT THE OCULAR SURFACE
    Publication number: 20230372360
    Abstract: Provided herein are pharmaceutical compositions comprising a therapeutically effective amount of a lipophilic compound and a pharmaceutically acceptable carrier adapted for peri-ocular transdermal delivery of the lipophilic compound to one or more periorbital glands and/or the ocular surface tissues of a subject. Further provided herein are methods of using such pharmaceutical compositions for providing relief of one or more signs or symptoms of an ocular disease, methods of using one or more Meibomian glands (and meibum therein) as a drug delivery system for a lipophilic compound (e.g., a steroid) to the ocular surface, and kits related thereto.
    Type: Application
    Filed: August 1, 2023
    Publication date: November 23, 2023
    Applicant: CS Pharmaceuticals Limited
    Inventors: Charles F. BOSWORTH, Achim H. KRAUSS
  • Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
    Patent number: 11759472
    Abstract: Provided herein are pharmaceutical compositions comprising a therapeutically effective amount of a lipophilic compound and a pharmaceutically acceptable carrier adapted for pen-ocular transdermal delivery of the lipophilic compound to one or more periorbital glands and/or the ocular surface tissues of a subject. Further provided herein are methods of using such pharmaceutical compositions for providing relief of one or more signs or symptoms of an ocular disease, methods of using one or more Meibomian glands (and meibum therein) as a drug delivery system for a lipophilic compound (e.g., a steroid) to the ocular surface, and kits related thereto.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: September 19, 2023
    Assignee: CS Pharmaceuticals Limited
    Inventors: Charles F. Bosworth, Achim H. Krauss
  • COMPOSITIONS AND METHODS OF USE FOR TREATING ABERRANT INFLAMMATION IN PERI-OCULAR SECRETORY GLANDS OR AT THE OCULAR SUFACE
    Publication number: 20190151334
    Abstract: Provided herein are pharmaceutical compositions comprising a therapeutically effective amount of a lipophilic compound and a pharmaceutically acceptable carrier adapted for pen-ocular transdermal delivery of the lipophilic compound to one or more periorbital glands and/or the ocular surface tissues of a subject. Further provided herein are methods of using such pharmaceutical compositions for providing relief of one or more signs or symptoms of an ocular disease, methods of using one or more Meibomian glands (and meibum therein) as a drug delivery system for a lipophilic compound (e.g., a steroid) to the ocular surface, and kits related thereto.
    Type: Application
    Filed: December 14, 2018
    Publication date: May 23, 2019
    Applicant: AxeroVision, Inc.
    Inventors: Charles F. BOSWORTH, Achim H. KRAUSS
  • COMPOSITION AND METHODS FOR THE TREATMENT OF BLEPHOPHAROPTOSIS
    Publication number: 20190000808
    Abstract: The present invention relates to compositions and methods for the treatment and prevention of ptosis and more specifically to compositions and methods for the non-surgical treatment and prevention of ptosis and methods for the improvement of night vision, administering a combination of pilocarpine and oxymetazoline.
    Type: Application
    Filed: July 6, 2016
    Publication date: January 3, 2019
    Inventors: Charles F. BOSWORTH, Houman D. HEMMATI, David A. HOLLANDER